May 20, 2024 | Advocacy, Diabetes Business, Featured, LOOPing, Podcasts, Research News, Technology Updates, Videos
Meet the newest insulin pump: all about “twiist” with Sequel CEO Alan Lotvin by Stacey Simms for Diabetes-Connections.com, 16 April 2024. This week, the newest pump coming to the market is called the twiist. It’s a very different shape – circular with a top half that...
Apr 29, 2024 | Advocacy, Diabetes Business, Featured, Foods, Research News
Introducing Cadisegliatin, a New Drug in the Type 1 Diabetes Pipeline by Ross Wollen for DiabetesDaily.com, 26 April 2024. Cadisegliatin, an investigative therapy currently entering phase 3 trials, could be the next important drug, after insulin, indicated for Type 1...
Apr 15, 2024 | A Little Humor, Advocacy, Diabetes Business, Research News, Technology Updates
Lilly’s Carelessness in Discontinuing 3 mL vials of Humalog Causes Shortages in 10 mL vials of Humalog + Unbranded Lispro by Scott Strumello for blog.sstrumello.com, 9 April 2024. In mid-March 2024, the JDRF shared news about how Eli Lilly & Company,...
Apr 8, 2024 | Advocacy, Diabetes Business, Featured, Foods, Research News, Technology Updates, Videos
The next-gen implantable bioartificial pancreas by Bernard Banga for Medical-Technology.nridigital.com, 22 September 2023. A team from MIT, in collaboration with researchers from Boston Children’s Hospital, has developed a novel implantable device. The...
Apr 1, 2024 | Advocacy, Diabetes Business, Eating, Featured, Foods, Research News, Technology Updates
Surgeons Transplant Pig Kidney Into a Patient, a Medical Milestone by Roni Caryn Rabin for NYTImes.com, 21 March 2024. Surgeons in Boston have transplanted a kidney from a genetically engineered pig into an ailing 62-year-old man, the first procedure of its kind. If...
Mar 11, 2024 | Advocacy, Diabetes Business, Research News
Sensulin’s Biotech Dream Team Is Bringing the Lowest-Cost Smart Insulin to Market by StartUp Health for HealthTransformer.co, 7 March 2024. Sensulin’s idea to create a “smart insulin” (glucose-responsive insulin or “GRI”) is not new. Three of the company’s co-founders...